Bayer, the multinational pharmaceutical and life sciences company, has announced a significant decision to cut its dividends to the legal minimum in an effort to reduce its debt. This move comes as Bayer faces financial challenges and seeks to strengthen its financial position.
The decision to reduce dividends to the legal minimum is a strategic one aimed at addressing Bayer's debt levels. By cutting dividends, the company aims to free up capital that can be used to pay down debt and improve its overall financial health. This move is part of Bayer's broader efforts to streamline its operations and focus on core business activities.
